This is a review of scientific literature, published from January 2014 to March 2018, considering licensed meningococcal vaccines and their role in prevention of IMD. The aim is to inform policy decisions around the routine use of these meningococcal vaccines in New Zealand. It is not a systematic review and does not consider cost-related analyses.